CYCLOBENZAPRINE HYDROCHLORIDE | A218936 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.2600
per ea
Lowest NADAC/Unit
$0.0177
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64980070501FEXMID 7.5 MG TABLET | $0.2600 | EA | Generic | — | 2026-06-17 |
| 64980065510CYCLOBENZAPRINE 5 MG TABLET | $0.0211 | EA | Generic | — | 2026-06-17 |
| 64980065550CYCLOBENZAPRINE 5 MG TABLET | $0.0211 | EA | Generic | — | 2026-06-17 |
| 64980065501CYCLOBENZAPRINE 5 MG TABLET | $0.0211 | EA | Generic | — | 2026-06-17 |
| 64980065701CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
| 64980065710CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
| 64980065750CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.